Search
Idarucizumab
go.drugbank.com/drugs/DB09264ApprovedIdarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its … Approved under the tradename Praxbind (FDA), idarucizumab is indicated for the emergency treatment of dabigatran-associated bleeding in life-threatening or surgically induced situations.
Iodohippuric acid
go.drugbank.com/drugs/DB15445InvestigationalIodohippuric acid is under investigation in clinical trial NCT02599844 (Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults).
Categories: Compounds used in a research, industrial, or household settingCentella asiatica
go.drugbank.com/drugs/DB14256ApprovedCentella asiatica is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Products: StemCell TeN 10 Revolutionary skin theraphyIndian frankincense
go.drugbank.com/drugs/DB14275ApprovedInvestigationalIndian frankincense is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Ex Colebr. Oleo-gum-resinGlycyrrhiza glabra
go.drugbank.com/drugs/DB14312ApprovedInvestigationalWithdrawnGlycyrrhiza glabra is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Glycyrrhizae Radix Et Rhizoma (Glycyrrhiza Glabra), Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle (Glycyrrhiza Glabra)Usnea barbata
go.drugbank.com/drugs/DB14351ApprovedUsnea barbata is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Saw palmetto
go.drugbank.com/drugs/DB14360ApprovedSaw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Methoxamine
go.drugbank.com/drugs/DB00723ApprovedInvestigationalWithdrawnAn alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system.
Albinterferon Alfa-2B
go.drugbank.com/drugs/DB05396InvestigationalIn response to an FDA ruling, Novartis and Human Genome Sciences announced on October 5, 2010 that they ceased development of the drug. … The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C.
Aldoxorubicin
go.drugbank.com/drugs/DB06013InvestigationalAldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.